182 related articles for article (PubMed ID: 30985703)
1. Effectiveness, safety, and economic evaluation of topical application of a herbal ointment, Jaungo, for radiation dermatitis after breast conserving surgery in patients with breast cancer (GREEN study): Study protocol for a randomized controlled trial.
Shin S; Jang BH; Suh HS; Park SH; Lee JW; Yoon SW; Kong M; Lim YJ; Hwang DS
Medicine (Baltimore); 2019 Apr; 98(15):e15174. PubMed ID: 30985703
[TBL] [Abstract][Full Text] [Related]
2. Topical application of Jaungo in atopic dermatitis patients: study protocol for a randomized, controlled trial.
Yun Y; Ko Y; Ahn JH; Jang BH; Kim K; Ko SG; Choi I
Trials; 2017 Apr; 18(1):176. PubMed ID: 28403910
[TBL] [Abstract][Full Text] [Related]
3. Randomized, Prospective, Open-label Phase III Trial Comparing Mebo Ointment With Biafine Cream for the Management of Acute Dermatitis During Radiotherapy for Breast Cancer.
Geara FB; Eid T; Zouain N; Thebian R; Andraos T; Chehab C; Ramia P; Youssef B; Zeidan YH
Am J Clin Oncol; 2018 Dec; 41(12):1257-1262. PubMed ID: 29889137
[TBL] [Abstract][Full Text] [Related]
4. Randomized, prospective assessment of moisturizer efficacy for the treatment of radiation dermatitis following radiotherapy after breast-conserving surgery.
Sekiguchi K; Ogita M; Akahane K; Haga C; Ito R; Arai S; Ishida Y; Tsukada Y; Kawamori J
Jpn J Clin Oncol; 2015 Dec; 45(12):1146-53. PubMed ID: 26491204
[TBL] [Abstract][Full Text] [Related]
5. Exploring the efficacy and safety of topical Jaungo application in patients with atopic dermatitis: A pilot randomized, double-blind, placebo-controlled study.
Ahn JH; Yun Y; Kim MH; Ko SG; Kim KS; Choi I
Complement Ther Med; 2018 Oct; 40():22-28. PubMed ID: 30219454
[TBL] [Abstract][Full Text] [Related]
6. Comparative Efficacy of Jaungo, A Traditional Herbal Ointment, and the Water-in-Oil Type Non-Steroidal Moisturizer for Radiation-Induced Dermatitis in Patients With Breast Cancer: A Study Protocol for a Prospective, Randomized, Single-Blinded, Pilot Study.
Kim EH; Yoon JH; Park SB; Lee JY; Chung WK; Yoon SW
Front Pharmacol; 2021; 12():751812. PubMed ID: 34621177
[No Abstract] [Full Text] [Related]
7. Randomized phase III study comparing Best Supportive Care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13.
Fisher J; Scott C; Stevens R; Marconi B; Champion L; Freedman GM; Asrari F; Pilepich MV; Gagnon JD; Wong G
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1307-10. PubMed ID: 11121627
[TBL] [Abstract][Full Text] [Related]
8. Topical use of phytotherapic cream (Capilen® cream) to prevent radiodermatitis in breast cancer: a prospective historically controlled clinical study.
Stefanelli A; Forte L; Medoro S; Sgualdo A; Lombardo D; Zini G; Maronta D; Rainieri E; Pascale G; Bagnolatti P; Colella M; Princivalle S; Fiorica F
G Ital Dermatol Venereol; 2014 Feb; 149(1):107-13. PubMed ID: 24566571
[TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin-3-gallate ameliorates radiation-induced acute skin damage in breast cancer patients undergoing adjuvant radiotherapy.
Zhu W; Jia L; Chen G; Zhao H; Sun X; Meng X; Zhao X; Xing L; Yu J; Zheng M
Oncotarget; 2016 Jul; 7(30):48607-48613. PubMed ID: 27224910
[TBL] [Abstract][Full Text] [Related]
10. Topical use of a silymarin-based preparation to prevent radiodermatitis : results of a prospective study in breast cancer patients.
Becker-Schiebe M; Mengs U; Schaefer M; Bulitta M; Hoffmann W
Strahlenther Onkol; 2011 Aug; 187(8):485-91. PubMed ID: 21786113
[TBL] [Abstract][Full Text] [Related]
11. Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4.
Miller RC; Schwartz DJ; Sloan JA; Griffin PC; Deming RL; Anders JC; Stoffel TJ; Haselow RE; Schaefer PL; Bearden JD; Atherton PJ; Loprinzi CL; Martenson JA
Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1460-6. PubMed ID: 20800381
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic treatment with a potent corticosteroid cream ameliorates radiodermatitis, independent of radiation schedule: A randomized double blinded study.
Ulff E; Maroti M; Serup J; Nilsson M; Falkmer U
Radiother Oncol; 2017 Jan; 122(1):50-53. PubMed ID: 27913066
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of an aloe vera, chamomile, and thyme cosmetic cream for the prophylaxis and treatment of mild dermatitis induced by radiation therapy in breast cancer patients: a controlled clinical trial (Alantel Trials).
Jimenez-Garcia C; Perula-de Torres LA; Villegas-Becerril E; Muñoz-Gavilan JJ; Espinosa-Calvo M; Montes-Redondo G; Romero-Rodriguez E;
Trials; 2024 Jan; 25(1):84. PubMed ID: 38273379
[TBL] [Abstract][Full Text] [Related]
14. Hydrosorb® versus control (water based spray) in the management of radio-induced skin toxicity: Results of multicentre controlled randomized trial.
Bazire L; Fromantin I; Diallo A; de la Lande B; Pernin V; Dendale R; Fourquet A; Savignoni A; Kirova YM
Radiother Oncol; 2015 Nov; 117(2):229-33. PubMed ID: 26328937
[TBL] [Abstract][Full Text] [Related]
15. A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients.
Ingargiola R; De Santis MC; Iacovelli NA; Facchinetti N; Cavallo A; Ivaldi E; Dispinzieri M; Franceschini M; Giandini C; Romanello DA; Di Biaso S; Sabetti M; Locati L; Alfieri S; Bossi P; Guglielmo M; Macchi F; Lozza L; Valdagni R; Fallai C; Pignoli E; Orlandi E
Radiat Oncol; 2020 Aug; 15(1):193. PubMed ID: 32791985
[TBL] [Abstract][Full Text] [Related]
16. Treatment of acute radiodermatitis with an oil-in-water emulsion following radiation therapy for breast cancer: a controlled, randomized trial.
Jensen JM; Gau T; Schultze J; Lemmnitz G; Fölster-Holst R; May T; Abels C; Proksch E
Strahlenther Onkol; 2011 Jun; 187(6):378-84. PubMed ID: 21603988
[TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy of Jaungo, a traditional herbal ointment, and a water-in-oil type non-steroidal moisturizer for radiation-induced dermatitis in patients with breast cancer: a prospective, randomized, single-blind, pilot study.
Kim EH; Park SB; Jin H; Chung WK; Yoon SW
Front Pharmacol; 2023; 14():1216668. PubMed ID: 37469863
[No Abstract] [Full Text] [Related]
18. A Randomized Trial of Mometasone Furoate 0.1% to Reduce High-Grade Acute Radiation Dermatitis in Breast Cancer Patients Receiving Postmastectomy Radiation.
Ho AY; Olm-Shipman M; Zhang Z; Siu CT; Wilgucki M; Phung A; Arnold BB; Porinchak M; Lacouture M; McCormick B; Powell SN; Gelblum DY
Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):325-333. PubMed ID: 29726361
[TBL] [Abstract][Full Text] [Related]
19. Randomized Pilot Study of a Keratin-based Topical Cream for Radiation Dermatitis in Breast Cancer Patients.
Winkfield KM; Hughes RT; Brown DR; Clohessy RM; Holder RC; Russell GB; Rejeski AF; Burnett LR
Technol Cancer Res Treat; 2024; 23():15330338231222137. PubMed ID: 38186361
[No Abstract] [Full Text] [Related]
20. Longitudinal trends in skin-related and global quality of life among women with breast radiodermatitis: A pilot study.
Beamer LC; Grant M
Eur J Oncol Nurs; 2018 Apr; 33():22-27. PubMed ID: 29551173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]